AS ONE (7476) investor relations material

Executive summary

• Achieved record-high net sales of ¥110.7 billion (+6.7% YoY) and operating profit of ¥12.8 billion (+10.7% YoY), marking the 16th consecutive year of growth, despite U.S. tariff impacts.

• Profit attributable to owners increased 11.5% to ¥9.18 billion; EPS rose to ¥128.35 (+11.7% YoY).

• E-commerce sales surged 12.8%, driving strong performance in research, lab, and industry segments, while the medical segment declined 1.0%.

• Annual dividend increased for the 15th consecutive year to ¥65 per share.

• Treasury stock acquisition and cancellation activities reduced outstanding shares.

Financial highlights

• Gross profit margin held steady at 30.2%; gross profit was ¥33.5 billion (+6.9% YoY).

• SG&A expenses rose 4.6% to ¥20.6 billion, with the ratio to sales falling by 0.4 points to 18.6%.

• Cash flows from operating activities were ¥6.47 billion, down from ¥9.31 billion the prior year.

• Cash and cash equivalents at year-end were ¥14.99 billion, down ¥4.04 billion YoY.

• Equity-to-asset ratio improved to 69.4%.

Outlook and guidance

• FY 03/2027 sales forecast: ¥117.85 billion (+6.5% YoY); operating profit: ¥12.9 billion (+0.5% YoY); ordinary profit: ¥13.35 billion (+0.9% YoY); profit attributable to owners: ¥8.97 billion (−2.3% YoY).

• Gross profit margin expected to remain stable at 30.3%.

• Anticipated special losses of ¥244 million from asset consolidation.

• Dividend forecast: ¥66 per share (+1.5% YoY).

• Impact from Middle East situation and other geopolitical risks not included in forecasts due to uncertainty.